NeuroMetrix, Inc. Announces Date for Second Quarter 2022 Financial Results Conference Call
July 14 2022 - 11:32AM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its 2022 second quarter financial results before the opening
of the market on July 21, 2022. The Company will host a conference
call at 8:00 a.m., Eastern Time on July 21, 2022 to discuss its
financial results as well as business developments affecting the
Company.
An audio-only webcast of the call, along with the earnings press
release and accompanying condensed financial statements, may be
accessed in the Investors section of the Company’s website at
www.NeuroMetrix.com. Under a new procedure, participants who wish
to access the call live via telephone to ask questions must
register in advance here. Upon registering, a dial-in and unique
PIN will be provided on screen and via email to join the call.
Following the conference call, a replay of the call will be
available for one year on the Company's website at
www.NeuroMetrix.com under the "Investor Relations" tab.
About NeuroMetrix
NeuroMetrix is an innovation-driven company with a mission to
improve individual and population health through innovative medical
devices and technology solutions for neurological disorders and
pain syndromes. The Company has three commercial products.
DPNCheck® is a diagnostic device that provides rapid, point-of-care
detection of peripheral neuropathies. ADVANCE® is a diagnostic
device that provides automated, in-office nerve conduction studies
for the evaluation of focal neuropathies. Quell® is a wearable
neuromodulation technology indicated for treatment of fibromyalgia
symptoms and chronic lower extremity pain. For more information,
visit www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024